Neuronetics
| Company type | Public |
|---|---|
| Industry | Medical devices |
| Founded | April 2003 |
| Headquarters | Malvern , United States |
| Products | NeuroStar TMS device |
| Website | neurostar |
Neuronetics is a publicly listed corporation headquartered in Malvern, Pennsylvania, incorporated in Delaware in April 2003. The company focuses on developing non-invasive neuromodulation therapies targeting psychiatric conditions that do not respond to conventional treatments.
Holding the distinction of being the first and sole recipient of FDA clearance for a transcranial magnetic stimulation (TMS) system designed specifically for patients with medication-resistant depression (FDA clearance K061053), Neuronetics produces the NeuroStar TMS device. This technology administers treatment via a magnetic coil precisely positioned on the patient’s scalp to deliver targeted therapy.